|Day Low/High||3.05 / 3.20|
|52 Wk Low/High||2.10 / 4.45|
- Estate Covers over 175 Patents for Physiocrine Biology, a New Class of Potential Targets and Therapeutics -
- Improved Muscle Strength Observed in 50% to 78% of Patients in Two Rare Genetically Distinct Myopathies -
-- First Reported Fast Track Designation for a FSHD Treatment --
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Here's a technical look at how to trade five stocks that are within range of triggering big breakouts.
Insiders at these companies have been scooping up shares of their own stock lately.
Shares of aTyr Pharma (LIFE) are climbing late Tuesday afternoon as BMO Capital began coverage of the stock with a ‘market perform’ rating and $8 price target.
These stocks look ready to break out and trade higher from current levels.
Data for Phase 1b/2 Clinical Trial of Resolaris in Adult FSHD Patients Expected at Approximately the End of First Quarter 2016